Sage Journals: Discover world-class research

Open access

Research article

First published 2011-8

Tolerability of initiation doses of once-monthly paliperidone palmitate in patients with recently diagnosed schizophrenia in an acute treatment trial

Cynthia A. Bossie, Dong-Jing Fu, Jennifer Kern Sliwa [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Review article

First published 2023-4

Invega Hafyera (Paliperidone Palmitate): Extended-Release Injectable Suspension for Patients With Schizophrenia

Lindsey Peters, Megan Dyer, Emily Schroeder [...]

Journal of Pharmacy Technology

Retricted access

Research article

First published 2011-5

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

S Gopal, U Vijapurkar, P Lim [...]

Journal of Psychopharmacology

Open access

Research article

First published 2022

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation

Olivier Corbeil, Anne-Marie Essiambre, Laurent Béchard [...]

Therapeutic Advances in Psychopharmacology

Open access

Research article

First published 2021-6

New Zealand community mental healthcare provider experience in schizophrenia management with 3-monthly paliperidone palmitate

Cathal Cassidy, Wayne Miles

Australasian Psychiatry

Open access

Research article

First published 2023

Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study

Juan Antonio García-Carmona, Alba García-Pérez, Guillermo Isidro García [...]

Therapeutic Advances in Psychopharmacology

Open access

Research article

First published 2020

Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia

Maria Paz Garcia-Portilla, Pierre-Michel Llorca, Giuseppe Maina [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Research article

First published 2012-10

An Analysis of Potentially Prolactin-Related Adverse Events and Abnormal Prolactin Values in Randomized Clinical Trials with Paliperidone Palmitate

Thomas R Einarson, Michiel EH Hemels, Isaac Nuamah [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2022-2

Incident infection during the first year of treatment – A comparison of clozapine and paliperidone palmitate long-acting injection

Shubhra Mace, Olubanke Dzahini, Victoria Cornelius [...]

Journal of Psychopharmacology

Open access

Research article

First published 2020

Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes

Katalin Pungor, Vasilis P. Bozikas, Robin Emsley [...]

Therapeutic Advances in Psychopharmacology

Search results